seed
Stage
1
Investors
About
Medherant develops transdermal drug delivery patches using a proprietary drug-in-adhesive platform with ionic liquid formulations to enable precise and sustained topical delivery of small-molecule drugs.
Explore Medherant Limited's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.